A tiny Atlanta biotech company hopes it can help stop what’s being called the “most severe acute health emergency in modern times.”Despite having no product revenue, only seven full-time employees, just 8,400 square feet in Smyrna, Ga., and less than $3 million to spend on research and development in 2014, GeoVax Labs Inc. believes it has a shot at beating Big Pharma in finding a preventive vaccine for Ebola.
Help employers find you! Check out all the jobs and post your resume.